Catheter Ablation of Atrial Fibrillation: What Are the Risks and Complications and How Do We Avoid Them?

  • S. Themistoclakis
  • A. Bonso
  • A. Rossillo
  • A. Raviele
Conference paper


Atrial fibrillation (AF) is the most common cardiac arrhythmia, with a prevalence of between 2% and 4% in the general population over 60 years old and an increasing incidence with age [1]. Its presence causes a rise in morbidity and mortality rates due to the increase of embolic risk and loss of atrial function with a consequent decrease in cardiac performance. Very often AF is associated with disabling symptoms-such as palpitations, exercise intolerance, and fatigue-that can influence the quality of life significantly. In patients affected by persistent or permanent AF with rapid ventricular response, the persistent high rate may produce a tachycardiomyopathy that can be reversible when sinus rhythm is restored or the ventricular rate is controlled. This arrhythmia is also a significant social financial burden. In the USA, AF causes more hospital admissions than any other arrhythmia, accounting for a nearly 1 million hospital days per year [2].


Atrial Fibrillation Pulmonary Vein Catheter Ablation Pulmonary Vein Isolation Atrial Fibrillation Ablation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kannel W, Wolff P, Benjamin E, Levy D (1998) Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol 82:2N–9NPubMedCrossRefGoogle Scholar
  2. 2.
    Murgatroyd FD, Camm AJ (1993) Atrail arrhythmias. Lancet 341:1317–1322PubMedCrossRefGoogle Scholar
  3. 3.
    Scheinman MM, Morady F (2001) Nonpharmacological approaches to atrial fibrillation. Circulation 103:2120–2125PubMedCrossRefGoogle Scholar
  4. 4.
    Haissaguerre M, Jais P, Shah DC et al (1996) Right and left atrial radiofrequency catheter ablation therapy of paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 7:1132–1144PubMedCrossRefGoogle Scholar
  5. 5.
    Gaita F, Riccardi R, Calo L et al (1998) Atrial mapping and radiofrequency catheter ablation in patients with idiopathic atrial fibrillation. Circulation 97:2136–2145PubMedCrossRefGoogle Scholar
  6. 6.
    Pappone C, Oreto G, Lamberti F (1999) Catheter ablation of paroxysmal atrial fibrillation using a 3D mapping system. Circulation 100:1203–1208PubMedCrossRefGoogle Scholar
  7. 7.
    Ernst S, Schlutter M, Ouyang F et al (1999) Modification of the substrate for maintenance of idiopathic human atrial fibrillation: efficacy of radiofrequency ablation using nonfluoroscopic catheter guidance. Circulation 100:2085–2092PubMedCrossRefGoogle Scholar
  8. 8.
    Robbins IM, Colvin EV, Doyle TP et al (1998) Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation 98:1769–1775PubMedCrossRefGoogle Scholar
  9. 9.
    Haissaguerre M, Jais P, Shah DC et al (1998) Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339:659–666PubMedCrossRefGoogle Scholar
  10. 10.
    Chen SA, Hsieh MH, Tai CT et al (1999) Initiation of atrial fibrillation by ectopic beats originating from the pulmonary veins: electrophysiological characteristics, pharmacological responses and effects of radiofrequency ablation. Circulation 100:1879–1886PubMedCrossRefGoogle Scholar
  11. 11.
    Haissaguerre M, Jais P, Shah DC et al (2000) Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary vein foci. Circulation 101:1409–1417PubMedCrossRefGoogle Scholar
  12. 12.
    Haissaguerre M, Shah DC, Jais P (2000) Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 102:2463–2465PubMedCrossRefGoogle Scholar
  13. 13.
    Arentz T, Jander N, von Rosenthal J et al (2003) Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation. Eur Heart J 24:963–969PubMedCrossRefGoogle Scholar
  14. 14.
    Purerfellner H, Cihal R, Aichinger J et al (2003) Pulmonary vein stenosis by ostial irrigated-tip ablation: incidence, time course and prediction. J Cardiovasc Electrophysiol 14:158–164PubMedCrossRefGoogle Scholar
  15. 15.
    Pappone C, Oreto G, Rosanio S et al (2001) Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation. Circulation 104:2539–2544PubMedCrossRefGoogle Scholar
  16. 16.
    Kanagaratnam L, Tomassoni G, Schweikert R et al (2001) Empirical pulmonary vein isolation in patients with chronic atrial fibrillation using a three-dimensional nonfluoroscopic mappig system: long-term follow-up. Pacing Clin Electrophysiol 24:1774–1779PubMedCrossRefGoogle Scholar
  17. 17.
    Natale A, Pisano E, Shewchik J et al (2000) First human experience with pulmonary vein isolation using a through-the-balloon circumferential ultrasound ablation system for recurrent atrial fibrillation. Circulation 102:1879–1882PubMedCrossRefGoogle Scholar
  18. 18.
    Saliba W, Wilber D, Packer D et al (2002) Circumferencial ultrasound ablation for pulmonary vein isolation: analysis of acute and chronic failures. J Cardiovasc Electrophysiol 13:957–961PubMedCrossRefGoogle Scholar
  19. 19.
    Marrouche NF, Dresing T, Cole C et al (2002) Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation: impact of different catheter technologies. J Am Coll Cardiol 40:464–474PubMedCrossRefGoogle Scholar
  20. 20.
    Marrouche NF, Martin DO, Wazni O et al (2003) Phased array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: impact on outcome and complications. Circulation 107:2710–2716PubMedCrossRefGoogle Scholar
  21. 21.
    Saad EB, Marrouche NF, Saad CP et al (2003) Pulmonary vein stenosis after catheter ablation of atrial fibrillation: emergence of a new clinical syndrome. Ann Intern Med 138:634–638PubMedGoogle Scholar
  22. 22.
    Kok LC, Everett TH, Akar JG et al (2003) Effect of heating on pulmonary veins: how to avoid pulmonary vein stenosis. J Cardiovasc Electrophysiol 14:250–254PubMedCrossRefGoogle Scholar
  23. 23.
    Taylor GW, Kay GN, Zheng X et al (2000) Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs. Circulation 101:1736–1742PubMedCrossRefGoogle Scholar
  24. 24.
    Ernst S, Ouyang F, Goya M et al (2003) Total pulmonary vein occlusion as consequence of catheter ablation for atrial fibrillation mimicking primary lung disease. J Cardiovasc Electrophysiol 14:366–370PubMedCrossRefGoogle Scholar
  25. 25.
    Kok LC, Mangrum JM, Haines DE et al (2002) Cerebrovascular complication associated with pulmonary vein ablation. J Cardiovasc Electrophysiol 13:764–767PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2004

Authors and Affiliations

  • S. Themistoclakis
    • 1
  • A. Bonso
    • 1
  • A. Rossillo
    • 1
  • A. Raviele
    • 1
  1. 1.Division of CardiologyUmberto I HospitalMestre-VeniceItaly

Personalised recommendations